Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Infect Dis ; 207(4): 588-93, 2013 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-23087434

RESUMO

We investigated oral fluid (OF) as an alternative to sampling of rashes for varicella zoster virus (VZV) genotyping and further characterized VZV clade prevalence in the United Kingdom and Europe. VZV was detected in up to 91% of OF specimens. Paired OF and vesicle fluid samples contained identical VZV clades. While clades 1 and 3 were the most prevalent across the United Kingdom and Europe, in Western Europe, clade 5 viruses were circulating. Viruses from the same outbreak belonged to different clades, but no clade was associated with a severe-disease phenotype. OF is suitable and convenient for large-scale molecular epidemiological studies of VZV.


Assuntos
Varicela/epidemiologia , Herpes Zoster/epidemiologia , Herpesvirus Humano 3/genética , Epidemiologia Molecular , Polimorfismo de Nucleotídeo Único , Saliva/virologia , Varicela/virologia , Europa (Continente)/epidemiologia , Genótipo , Herpes Zoster/virologia , Herpesvirus Humano 3/isolamento & purificação , Humanos , Boca/virologia , Prevalência , Sensibilidade e Especificidade , Pele/patologia , Pele/virologia , Reino Unido/epidemiologia
2.
Dig Liver Dis ; 43(11): 850-5, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-21596633

RESUMO

Ribavirin remains today a pivotal drug in the treatment of hepatitis C; in standard double therapy, as well as in triple combination with direct antiviral agents, ribavirin reduces relapse and can double the sustained virological response obtained with peginterferon alone or in association with direct antiviral agents. In the complex network of interacting factors determining sustained virological response independently of known predictive factors related to host and virus, two modern tools are emerging: polymorphisms in the IL28B gene and very early exposure to ribavirin. The use of a pharmacokinetic-pharmacodynamic model of early ribavirin exposure to adjust the dose individually would help promote a safer ribavirin use and improve sustained virological response. The variability of the influence of ribavirin exposure on anaemia is probably genetically determined; however, the low prevalence of the implicated protective alleles of the inosine triphosphate pyrophosphatase gene could explain their lack of influence on sustained virological response.


Assuntos
Antivirais/uso terapêutico , Hepacivirus/efeitos dos fármacos , Hepatite C/tratamento farmacológico , Interleucinas/genética , Ribavirina/uso terapêutico , Anemia/induzido quimicamente , Anemia/genética , Antivirais/efeitos adversos , Antivirais/farmacocinética , Quimioterapia Combinada , Hepatite C/genética , Humanos , Interferon alfa-2 , Interferon-alfa/uso terapêutico , Interferons , Polietilenoglicóis/uso terapêutico , Pirofosfatases/genética , Proteínas Recombinantes/uso terapêutico , Ribavirina/efeitos adversos , Ribavirina/farmacocinética , Carga Viral
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA